Staying Informed

OPKO Records Highly Successful Exit of Investment in Sorrento Therapeutics

OPKO Health, Inc. has completed the sale of its stake in Sorrento Therapeutics, Inc. , a publicly-traded, clinical-stage biopharmaceutical company focused primarily on the acquisition, discovery, development and commercialization of proprietary therapeutics .
Business For Sale in Miami News Snippet brought to you by:
BizLocal provides a Business For Sale Market Place and more. 
A web-property of Inspetta LLC, providing innovative web, software and marketing services to business.  
Call 800-785-2925 for more information.
Only registered users can leave comments.
Comment text: